True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India

Asian Journal of Transfusion Science

Volumn 6, Issue 2, 2012, Pages 165-168

  Tulsiani, Sunita ^a   Choudhury, Nabajyoti ^b   Desai, Priti ^c   Shah, Ripal ^d   Mathur, Ankit ^e   Harimoorthy, V ^f   Shah, Jwalant ^g  

^a Jeevan Jyoti Blood Bank ^*  (India)

^b Tata Medical Centre   (India)

^c TATA MEMORIAL HOSPITAL   (India)

^d Gujarat State Council for Blood Transfusion (GSCBT)   (India)

^e TTK Blood Bank   (India)

^f Prathama Blood Center   (India)

^g Lambda Pathology Lab   (India)

Author keywords

Anti Hepatitis C Virus Enzyme linked immunosorbent assay; nucleic acid amplification test; recombinant immuno blot assay

Indexed keywords

EID: 84876334509     PISSN: 09736247     EISSN: 19983565     Source Type: Journal    
DOI: 10.4103/0973-6247.98927     Document Type: Article

References (16)

1. Dhingra N. Blood Safety in developing world and WHO initiatives. Vox Sang 2000;83:173-7.
2. Sharma UK, Stramer SL, Wright DJ, Glynn SA, Hermansen S, Schreiber GB, et al. Impact of changes in viral marker screening assays. Transfusion 2003;43:202-4.
3. Tucker TJ, Voigt M. Bird A, Robson S, Gibbs B, Kanneyer J, et al. Hepatitis C virus infection rate in volunteer blood donors from the Western Cape - comparison of screening tests and PCR. S Afr Med J 1997;87:603-5.
4. KimYS, Lee HS, Ahn YO. Factors associated with positive predictability of Anti-HCV ELISA method with confirmatory RTPCR. J Korean Med Sci 1999;14:629-34.
5. Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, et al. Significance of the signal-to - cut off ratios of ant-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Transfusion 2005;46:163-71.
6. Alter MJ, Kuhnert WL, Finelli LF. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 2003;52:1-14
7. Piro L, Solinas S, Lucian M, Casale A, Bighiani T, Santonocito D, et al. Prospective study of the meaning of indeterminate results of the recombinant immunoblot assay for hepatitis C virus in blood donors. Transfusion 2008;6:107-11.
8. Kleinman SH, Stramer SL, Brodsky JP, Caglioti S, Busch MP. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: Implications for donor counseling and revision of existing algorithms. Transfusion 2006;46:695-702.
9. Dow BC, Buchanan I, Munro H. Relevance of RIBA-3 supplementary tests to HCV PCR positivity and genotypes for HCV confirmation of blood donors. J Med Virol 1996;49:132-6
10. Molin GD, Tiribelli C, Campello C. A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection. Ann Hepatol 2003;2:76-83.
11. Seed CR, Margaritis AR, Bolton WV, Kiely P, Parker S, Piscitelli L. Improved efficiency of national HIV, HCV and HTLV antibody testing algorithms based on sequential screening immunoassays, Transfusion 2003;43:226-34.
12. Kita M, Deguchi M, Kagita M, Yoshioka N, Kobayashi E, Watanabe M, et al. Clinical utility and characteristics of nine anti-HCV antibody screening reagents used in Japan. Clin Lab 2009;55:9-22.
13. Hejjas M, Medgyesi GA, Falus A, Hajnal A, Forster T, Szabo J. HCV antibodies in Hungarian blood donations. Experience collected by ELISA tests, immunoblot assays and polymerase chain reaction and protocol for donor management. Transfus Med 1994;4:273-80.
14. Anonymous. Using screening assays for TTIs. In Safe blood and blood products. Screening for HIV and other infectious agents. WHO Module 2002;2:83-4.
15. Vrielink H, Reesink HL, Zaaijer HL, Scholten E, Kremer LC, Cuypers HT, et al. Lookback of anti-HCV ELISA positive, HCVRNA PCR-negative donors and recipients of their blood products. Vox Sang 1997;72:67-70.
16. Moore MC, Howell DR, Barbara JA. Donors whose blood reacts falsely positive in transfusion microbiology screening assays need not be lost to transfusion. Transfus Med 2007;17:55-9.